SPRO
Spero Therapeutics, Inc. Common StockstockNASDAQ
At CloseNov 18, 2026 3:59:43 PM EST
0.87USD-3.362%(-0.03)273,023
Pre-marketNov 18, 2026 9:17:30 AM EST
0.9167USD+1.709%(+0.0154)
After-hoursNov 18, 2026 4:00:30 PM EST
0.874USD+0.344%(+0.003)
SPRO Financials
In Q3 FY 2026 (ended ), Spero Therapeutics, Inc. Common Stock (SPRO) reported revenue of $0, net income of −$44.28M, operating cash flow of −$42.61M, and assets of $110.03M (filed ).
Loading financial statements…
